Intra-Cellular Therapies, Inc. (ITCI)

Intra-Cellular Therapies Revenue

In the year 2024, Intra-Cellular Therapies had annual revenue of $680.85M with 46.62% growth. Intra-Cellular Therapies had revenue of $199.22M in the quarter ending December 31, 2024, with 50.81% growth.

• Revenue (ttm): $680.85M
• Revenue Growth: +46.62%
• P/S Ratio: 19.48
• Revenue / Employee: $1,116,151
• Employees: 610
• Market Cap: 13.66B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	680.85M	216.48M	46.62%
Dec 31, 2023	464.37M	214.06M	85.51%
Dec 31, 2022	250.31M	166.51M	198.69%
Dec 31, 2021	83.80M	60.99M	267.35%
Dec 31, 2020	22.81M	22.75M	37,537.14%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.